363 related articles for article (PubMed ID: 23517596)
1. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer.
Singh V; Sharma P; Capalash N
Curr Cancer Drug Targets; 2013 May; 13(4):379-99. PubMed ID: 23517596
[TBL] [Abstract][Full Text] [Related]
2. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
3. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
Datta J; Ghoshal K; Denny WA; Gamage SA; Brooke DG; Phiasivongsa P; Redkar S; Jacob ST
Cancer Res; 2009 May; 69(10):4277-85. PubMed ID: 19417133
[TBL] [Abstract][Full Text] [Related]
4. Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer.
Li YC; Wang Y; Li DD; Zhang Y; Zhao TC; Li CF
J Cell Biochem; 2018 Feb; 119(2):2440-2449. PubMed ID: 28926119
[TBL] [Abstract][Full Text] [Related]
5. Modulation of DNA methylation by a sesquiterpene lactone parthenolide.
Liu Z; Liu S; Xie Z; Pavlovicz RE; Wu J; Chen P; Aimiuwu J; Pang J; Bhasin D; Neviani P; Fuchs JR; Plass C; Li PK; Li C; Huang TH; Wu LC; Rush L; Wang H; Perrotti D; Marcucci G; Chan KK
J Pharmacol Exp Ther; 2009 May; 329(2):505-14. PubMed ID: 19201992
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
Rajendran G; Shanmuganandam K; Bendre A; Muzumdar D; Goel A; Shiras A
J Neurooncol; 2011 Sep; 104(2):483-94. PubMed ID: 21229291
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation as a target of epigenetic therapeutics in cancer.
Li KK; Li F; Li QS; Yang K; Jin B
Anticancer Agents Med Chem; 2013 Feb; 13(2):242-7. PubMed ID: 22934696
[TBL] [Abstract][Full Text] [Related]
8. New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.
Gros C; Fleury L; Nahoum V; Faux C; Valente S; Labella D; Cantagrel F; Rilova E; Bouhlel MA; David-Cordonnier MH; Dufau I; Ausseil F; Mai A; Mourey L; Lacroix L; Arimondo PB
J Biol Chem; 2015 Mar; 290(10):6293-302. PubMed ID: 25525263
[TBL] [Abstract][Full Text] [Related]
9. DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells.
Hossain MZ; Healey MA; Lee C; Poh W; Yerram SR; Patel K; Azad NS; Herman JG; Kern SE
Oncotarget; 2013 Feb; 4(2):298-309. PubMed ID: 23593653
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
[TBL] [Abstract][Full Text] [Related]
12. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
[TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferase inhibitors-state of the art.
Goffin J; Eisenhauer E
Ann Oncol; 2002 Nov; 13(11):1699-716. PubMed ID: 12419742
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C
Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969
[TBL] [Abstract][Full Text] [Related]
16. Procainamide is a specific inhibitor of DNA methyltransferase 1.
Lee BH; Yegnasubramanian S; Lin X; Nelson WG
J Biol Chem; 2005 Dec; 280(49):40749-56. PubMed ID: 16230360
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of motor neuron cell death through DNA methylation.
Chestnut BA; Chang Q; Price A; Lesuisse C; Wong M; Martin LJ
J Neurosci; 2011 Nov; 31(46):16619-36. PubMed ID: 22090490
[TBL] [Abstract][Full Text] [Related]
18. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
Fandy TE
Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
[TBL] [Abstract][Full Text] [Related]
19. Effect of Withaferin-A, Withanone, and Caffeic Acid Phenethyl Ester on DNA Methyltransferases: Potential in Epigenetic Cancer Therapy.
Kumar V; Dhanjal JK; Sari AN; Khurana M; Kaul SC; Wadhwa R; Sundar D
Curr Top Med Chem; 2024; 24(4):379-391. PubMed ID: 37496252
[TBL] [Abstract][Full Text] [Related]
20. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells.
Han H; Yang X; Pandiyan K; Liang G
PLoS One; 2013; 8(9):e75136. PubMed ID: 24040395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]